No Data
No Data
Lexeo Stock Drops 24% Amid Friedreich Ataxia Study Results
We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate
Larimar Stock Rallies 24% on FDA Removal of Partial Clinical Hold
Design Therapeutics Inc (DSGN) Q1 2024 Earnings: A Detailed Financial and Strategic Review
Hold Rating Maintained for Design Therapeutics Amid Strategic Updates and Financial Review
RBC Capital Reaffirms Their Hold Rating on Design Therapeutics (DSGN)
No Data
Trytosaveabit : Ty! Yes it’s been on a decent uptrend on very low daily volume! Yesterday was a great climb again on less than 300K volume! I believe it’s recovering from the crash from FDA hold a few months ago?
Newbee4 OP Trytosaveabit : TY. GL today and everyday
. Safe travels tomorrow ![heart ❤️](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/2764-fe0f.png)
Trytosaveabit Newbee4 OP : Thank you pretty gal!![gift_heart 💝](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f49d.png)